EPO patent granted
Innoprot is pleased to announce the granting of EPO (European Patent Office) patent on its core GPCR Screening technology on June 7th 2017. Innoprot received notice of the granting of EPO (European Patent Office) patent on its core technology for GPCR Screening. This broadens proprietary protection of the company’s core technology to all European countries.…